Access

Published online 10 August 2005 | Nature | doi:10.1038/news050808-9

News

Bird flu vaccine not up to scratch

Positive results of little practical use, experts warn.

The US National Institutes of Health (NIH) last weekend announced preliminary results of tests in people of a vaccine against the H5N1 avian flu virus, showing that two large doses should protect adults from infection.

But critics point out that the large amounts needed mean the hundreds of millions of doses needed to tackle a pandemic could never be produced.

Comments

Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.